1. 2020
  2. Non-mouse-adapted H1N1pdm09 virus as a model for influenza research

    Kiseleva, I., Rekstin, A., Al Farroukh, M., Bazhenova, E., Katelnikova, A., Puchkova, L. & Rudenko, L., 1 Jun 2020, In: Viruses. 12, 6, 590.

    Research output: Contribution to journalArticlepeer-review

  3. A phase 1 randomized placebo-controlled study to assess the safety, immunogenicity and genetic stability of a new potential pandemic H7N9 live attenuated influenza vaccine in healthy adults

    Kiseleva, I., Isakova-Sivak, I., Stukova, M., Erofeeva, M., Donina, S., Larionova, N., Krutikova, E., Bazhenova, E., Stepanova, E., Vasilyev, K., Matyushenko, V., Krylova, M., Galatonova, J., Ershov, A., Lioznov, D., Sparrow, E. G., Torelli, G. & Rudenko, L., Jun 2020, In: Vaccines. 8, 2, p. 1-20 20 p., 296.

    Research output: Contribution to journalArticlepeer-review

  4. Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus?

    Kiseleva, I., Stepanova, E., Krutikova, E., Donina, S., Rekstin, A. R., Bazhenova, E., Pisareva, M., Katelnikova, A., Kryshen, K., Muzhikyan, A., Grigorieva, E. & Rudenko, L., 11 Apr 2020, In: Vaccine Research (VacRes). 6, 1, p. 12-23

    Research output: Contribution to journalArticlepeer-review

  5. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 — Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines

    Krutikova, E. V., Stepanova, E. A., Wong, P. F., Kiseleva, I. V., Grigor’eva, E. P. & Rudenko, L. G., 1 Mar 2020, In: Bulletin of Experimental Biology and Medicine. 168, 5, p. 669-672 4 p.

    Research output: Contribution to journalArticlepeer-review

  6. Live attenuated potentially pandemic H5 vaccines on cold-adapted A/Leningrad/134/17/57 master donor virus backbone

    Kiseleva, I. & Larionova, N., 2020, Recent Progress in Microbiology and Biotechnology. Vol. 1. p. 14-30

    Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

  7. Neutralizing epitope of the fusion protein of respiratory syncytial virus embedded in the ha molecule of LAIV virus is not sufficient to prevent rs virus pulmonary replication but ameliorates lung pathology following RSV infection in mice

    Kotomina, T., Isakova-Sivak, I., Stepanova, E., Mezhenskaya, D., Matyushenko, V., Prokopenko, P., Sivak, K., Kiseleva, I. & Rudenko, L., 2020, In: Open Microbiology Journal. 14, 1, p. 147-156 10 p.

    Research output: Contribution to journalArticlepeer-review

  8. 2019
  9. Sequential immunization with universal live attenuated influenza vaccine candidates protects ferrets against a high-dose heterologous virus challenge

    Isakova-Sivak, I., Matyushenko, V., Kotomina, T., Kiseleva, I., Krutikova, E., Donina, S., Rekstin, A., Larionova, N., Mezhenskaya, D., Sivak, K., Muzhikyan, A., Katelnikova, A. & Rudenko, L., Sep 2019, In: Vaccines. 7, 3, 61.

    Research output: Contribution to journalArticlepeer-review

  10. Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

    Shcherbik, S., Pearce, N., Carney, P., Bazhenova, E., Larionova, N., Kiseleva, I., Rudenko, L., Kumar, A., Goldsmith, C. S., Dugan, V., Stevens, J., Wentworth, D. E. & Bousse, T., 9 Aug 2019, In: Vaccine: X. 2, 100031.

    Research output: Contribution to journalArticlepeer-review

  11. Experimental Study of Genetic Constellation of Cold-Adapted Master Donor Viruses for Live Attenuated Influenza Vaccine Type B

    Krutikova, E. V., Stepanova, E. A., Kiseleva, I. V. & Rudenko, L. G., 15 Jul 2019, In: Bulletin of Experimental Biology and Medicine. 167, 3, p. 384-387 4 p.

    Research output: Contribution to journalArticlepeer-review

  12. Will we ever be able to defeat human influenza?

    Kiseleva, I., 2019, In: Open Microbiology Journal. 13, 1, p. 313-314 2 p.

    Research output: Contribution to journalLetterpeer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 194343